Arthur F. Kluge, PH.D

Dr. Kluge has joined Tudor Risk Services as a strategic advisor. He brings a distinguished experience of working in multi-national pharmaceutical companies dedicated to creating and marketing innovative drugs for the treatment of cancer, arthritis, pain, cardiovascular disorders and infection. Dr. Kluge spent the first part of his career at Syntex, a +$2 billion multi-national Pharma company, where he directed a large chemical institute that delivered medicinal chemistry, process chemistry and radiochemistry services. Following the acquisition of Syntex by Roche, Dr. Kluge moved to the biotechnology industry performing key senior executive roles at Cubist Pharmaceuticals and GPC Biotech. Dr. Kluge taught at both Ohio State University as an Assistant Professor and Stanford University as an Adjunct Professor in the Department of Chemistry for over 10 years. Dr. Kluge holds a Ph.D. and M.S. in Organic Chemistry from the University of Massachusetts and an M.B.A. from the University of Santa Clara.

See listing of Dr. Kluge’s Scientific Publications (PDF file, 124 KB)